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Brown adipose tissue (BAT) promotes a lean and healthy phenotype and improves 
insulin sensitivity1. In response to cold or exercise brown fat cells also emerge in the 
white adipose tissue (named beige cells), a process known as browning2,3,4. Here, we 
show that the development of functional beige fat is promoted by microbiota 
depletion either by antibiotic treatment or in germ-free mice within the inguinal 
subcutaneous and perigonadal visceral adipose tissues (ingSAT and pgVAT, 
respectively). This leads to improved glucose tolerance, insulin sensitivity and 
decreased white fat and adipocyte size in lean mice and obese leptin-deficient 
(ob/ob) and high fat diet (HFD)-fed mice. These metabolic improvements are 
mediated by eosinophil infiltration and enhanced type 2 cytokine signaling and M2 
macrophage polarization in the subcutaneous white fat depots of microbiota-
depleted animals. The metabolic phenotype and the browning of the subcutaneous 
fat are impaired by suppression of the type 2 signaling and are reversed by 
recolonization of the antibiotic-treated, or the germ-free mice with microbes. These 
results provide insight into microbiota-fat signaling axis and beige fat development 
in health and metabolic disease. 
 
The intestinal microbiota is established with the development of the host, and its 
composition is influenced by several physiological changes, including obesity and 
pregnancy5,6,7. The intestinal microbiota can also influence host metabolism8 and insulin 
sensitivity9,10. To address the metabolic effects of complete microbiota depletion, we 
used an antibiotic cocktail supplemented in drinking water (Abx) and germ-free (GF) 
mice, and in agreement with the previous work10-12 showed improvements in insulin 
sensitivity and tolerance to oral and intraperitoneal glucose challenge in both animal 
models (Fig. 1a–d, Supplementary Fig. 1a–d). The insulin sensitivity of the microbiota-
depleted Abx mice was further investigated using hyperinsulinemic-euglycemic clamp in 
awake and unrestrained C57Bl/6J mice. Antibiotic administration led to a marked 
increase in the glucose infusion rates needed to maintain the clamped glucose levels, and 
to an increase in the stimulated rate of whole-body glucose disappearance (Rd) levels, 
while both the basal, and the final insulin levels were lower (Fig. 1e, Supplementary 
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Fig. 2a,b). These results demonstrate that microbiota depletion improves insulin 
sensitivity.  
To investigate peripheral glucose uptake, we co-administered 2-
[14C]deoxyglucose (2[14C]-DG) during the clamp. While no changes were observed in 
glucose uptake from the interscapular BAT (iBAT), quadriceps muscle, brain, or in 
hepatic glucose production, there was an increased uptake from the ingSAT and pgVAT, 
and a decrease from the soleus muscle (Fig. 1f,g, Supplementary Fig. 2c–h). These 
results suggest that the white fat depots are the main glucose disposal tissues in 
hyperinsulinemic conditions, which was further corroborated using positron emission 
tomography-computed tomography (MicroPET-CT). Specifically, 
[18F]fluorodeoxyglucose ([18F]FDG) uptake in iBAT increased following 12 h cold 
exposure, but did not differ between the groups. In contrast, Abx mice showed increased 
[18F]FDG uptake in both ingSAT and pgVAT, which was not changed by cold exposure 
(Fig. 1h, Supplementary Fig. 3a–d). 2-[1-3H]deoxyglucose (2-DG) uptake during 
intraperitoneal glucose challenge following 12 h cold exposure further demonstrated that 
ingSAT and pgVAT are the main glucose disposal tissues affected by microbiota 
depletion (Supplementary Fig. 3e–j). Together, this demonstrates that microbiota 
depletion leads to increased glucose disposal specifically in the WAT depots, both in 
hyperinsulinemic and in basal conditions. Antibiotic treatment also led to a decrease in 
the volume and weight of ingSAT, pgVAT, and interscapular SAT (iSAT) (Fig. 1i, 
Supplementary Fig. 4a,b), increased food intake and stool output (Supplementary Fig. 
4c–e). These results were consistent with the data we obtained from GF mice, and were 
confirmed using multidetector computed tomography (CT) (Supplementary Fig. 4f,g). 
Hounsfield unit analysis of the MicroPET-CT scans revealed that Abx mice had higher 
ingSAT and pgVAT density compared to controls, and that these differences were 
increased following 12 h of cold exposure (Fig. 1j, Supplementary Fig. 3j). 
We next investigated whether the higher density and the decreased fat amount are 
originating from differences in adipocyte volume. Measuring the adipocyte size 
distribution using high content imaging revealed that Abx and GF mice had an increased 
number of small and a decreased number of large adipocytes in both ingSAT and pgVAT 
depots (Fig. 2a,b). Morphologically, there were an increased number of smaller 
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adipocytes in both white fat depots with a multilocular phenotype (Fig. 2c), and the 
adipose depots excised from the microbiota-depleted animals were darker in appearance 
(Supplementary Fig. 4h). These features are characteristic of mature beige adipocytes. 
Therefore, we investigated whether microbiota depletion could affect the browning of the 
white fat depots. Both Abx and GF mice showed increases in brown fat specific markers 
in the ingSAT and in the pgVAT depots (Fig. 2d,e). The increased ingSAT and pgVAT 
browning was confirmed by high content imaging and suggested increased Ucp1-positive 
cells in both microbiota depleted animal models, accompanied by increased 3,5,3'-
Triiodothyronine (T3) levels in the GF mice (Fig. 2f, Supplementary Fig. 5a–c). These 
data suggest that microbiota depletion leads to browning of white adipose tissues from 
subcutaneous and visceral depots. The browning was present already 10 days after the 
microbiota depletion, and further increased after 40 and 60 days (Fig. 2d, 
Supplementary Fig. 5d–g). Body temperature measurements demonstrated that the 
initially more pronounced temperature drop observed in Abx mice after acute cold 
exposure normalized to control levels after six weeks of treatment, despite the lower 
energy harvest from the food (Supplementary Fig. 5h,i)13. Accordingly, mice 
repopulated with microbiota from control mice, which maintained the increased 
browning markers 10 days after transplantation, had increased glucose levels during cold 
exposure, and showed complete tolerance to acute cold (Supplementary Fig. 5i–k) 
suggesting that the newly developed beige fat is functionally active. The increased 
thermogenic capacity was further confirmed by oxygen consumption rate (OCR) 
measurements after isoproterenol stimulation, where adipocytes isolated from the Abx 
mice showed greater response compared to cells from control mice (Figure 2g).  
To investigate the reversibility of the browning after microbiota transplantation, 
we conventionalized GF mice with microbiota from control (GF conventionalized) or 
with residual microbiota from Abx mice; expansion of the microbiota in the mice 
colonized with microbiota from Abx mice was suppressed, or not, with continuous 
antibiotic treatment of the recipient GF mice (GFAbxT, GFAbxTstop, respectively). 
Compared to GFAbxT, GF conventionalized and GFAbxTstop mice had decreased 
glucose tolerance and insulin sensitivity, increased white fat weight and cell size, and 
diminished browning (as assessed by brown fat marker expression) 5 and 7.5 weeks after 
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transplantation (Fig. 2h–j, Supplementary Fig. 5l–o, Supplementary Fig. 6a–d). 
GFAbxT and GF mice did not show differences in expression of the browning markers 
and the size of adipocytes, suggesting that the residual microbiota present after the 
antibiotic treatment did not affect the increased browning observed in the GF mice (Fig. 
2j, Supplementary Fig. 6b–d). These results were consistent with the repopulated Abx 
mice, which showed decreased glucose tolerance, impaired insulin sensitivity and 
reversal of the browning of white fat depots after 30 days repopulation (Supplementary 
Fig. 6e–h). We extended these studies to mice kept at thermoneutrality, where the 
increased browning capacity would be driven by the microbiota depletion alone, 
excluding the effect of the environmental temperature14. Microbiota depletion also led to 
increased glucose tolerance and insulin sensitivity at thermoneutral conditions, decreased 
amounts of ingSAT and pgVAT and smaller adipocytes, along with increased browning 
markers expression, albeit to a lower magnitude compared to mice kept at RT, which is 
consistent with the absence of a mild thermal stimulation (Figure 3a-c, Supplementary 
Fig. 7a–e). Antibiotic treatment led to improvements in the tolerance to glucose, 
sensitivity to insulin, increased browning and thermogenic capacity in obese, leptin 
deficient (ob/ob) and high fat diet (HFD) fed mice (Figure 3d–j, Supplementary Fig. 
7f–h), demonstrating that microbiota depletion also promotes improved metabolic fitness 
of obese animals. 
To assess the mechanisms of browning, we profiled the cytokine levels in the 
ingSAT, and found that several type 1 and 2 cytokines were increased in Abx mice 
(Supplementary Fig. 8). Eosinophils, and the type 2 cytokines IL-4, IL-13, and IL-5 are 
sufficient to promote beige fat development through alternative activation of M2 
macrophages expressing tyrosine hydroxylase (TH)15-17,18, a rate-limiting enzyme in 
catecholamine biosynthesis19. These were the most significantly up-regulated cytokines 
following microbiota depletion in the ingSAT (Fig. 4a), but not in the intestine of the 
same animals (Supplementary Fig. 8). Th mRNA and TH protein levels were increased 
in ingSAT after 10 d, and still present after 40 and 60 d of microbiota depletion (Fig. 4b–
d). The type 2 cytokines were also increased in the pgVAT, but only mildly in the iBAT, 
bordering significance (Supplementary Fig. 9a,b). Using flow cytometry we detected 
increased frequency of eosinophils and macrophages in the ingSAT, but not in iBAT of 
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the microbiota-depleted mice. This was accompanied with an enhanced presence of 
CD301 and TH positive M2-polarized macrophages in the ingSAT (Fig. 4e–g, 
Supplementary Fig. 9c–k), suggesting that alternatively activated macrophages are 
associated with the increased ingSAT browning. Accordingly, when compared to the 
microbiota depleted wt mice, antibiotic-treated IL4 receptor alpha knock-out (Il4ra-KO, 
Il4ra–/–) mice showed suppressed cold and glucose tolerance, decreased insulin 
sensitivity, glucose uptake and browning of ingSAT, but not of pgVAT (Fig. 4h,i, 
Supplementary Fig. 10a–i). The loss of metabolic improvements in Il4ra-KO mice 
suggests that the ingSAT dominantly contributes to the observed metabolic effects of 
microbiota depletion, and indicates that additional mechanisms could mediate the pgVAT 
browning20. Finally, increased eosinophil and TH positive M2 macrophages were also 
detected in ingSAT, but not in pgVAT of the thermoneutral mice after microbiota 
depletion (Fig. 4j, Supplementary Fig. 10j–l), demonstrating that the increased ingSAT 
browning and glucose phenotype after the microbiota depletion are mediated by the 
increased type 2 signaling in both room temperature and thermoneutral mice.  
Together, our results demonstrate that microbiota depletion stimulates beige fat 
development in ingSAT and pgVAT, concomitant with increased type 2 cytokine 
signaling in these tissues. Inhibition of the type 2 signaling impairs antibiotic-induced 
subcutaneous fat browning and suppresses the glucose phenotype of the microbiota-
depleted mice. This alternative beige fat and macrophage activation opens new insights 
into the microbiota-fat signaling axis, beige fat development and insulin sensitivity, and 
suggests novel therapeutic approaches for treatment of obesity and the associated 
metabolic disorders.  
 
Methods 
Methods and the associated references are available in the online version of the paper.  
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Figure Legends 
Figure 1. Microbiota depletion directs glucose uptake primarily to the WAT and 
improves the sensitivity to insulin. (a,b) Insulin tolerance tests (ITT) in Abx (a), or GF 
mice (b) compared to the respective controls. Values are normalized to 0 min. (c,d) Oral 
glucose tolerance tests (OGTT) of Abx (c), or GF mice (d) compared to the respective 
controls. All values in (a-d) show mean ± sd. (n = 8 per group). (e) Glucose infusion rate 
(GIR) and rate of whole-body glucose disappearance (Rd) during hyperinsulinemic-
euglycemic clamp in awake and unrestrained C57Bl/6J mice as in (a). Bars show mean ± 
sd (n = 6 per group). (f,g) Tissue-specific 2[14C]deoxyglucose (2[14C]-DG) uptake in 
ingSAT (f), and pgVAT (g) during hyperinsulinemic-euglycemic clamp in awake 
C57Bl/6J mice as in (a). (h) Standardized Uptake Values (SUVs) of the radiolabeled 
tracer 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) from the MicroPET-CT in ingSAT in 
mice as in (a) kept at room temperature, or exposed to 6 °C for 12 hrs. (i) 3D 
reconstitution of the ingSAT and pgVAT (left) and quantification of the total ingSAT 
volume (right) from mice as in (a) using the MicroPET-CT scans. Scale bar: 5 mm. (j) 
Density of the ingSAT represented in Hounsfield units from mice as in (a). All bars show 
mean ± sd (n = 6 per group). Significance was calculated using non-paired two tailed 
Students t-test.*: P  ≤ 0.05, **: P  ≤ 0.01, ***: P ≤ 0.001.  
 
Figure 2. Microbiota depletion promotes browning of ingSAT and pgVAT. (a,b) Cell 
size profiling of adipocytes from ingSAT (a) and pgVAT (b) fat of control and 40 days 
treated Abx mice. Points show mean of pooled fractions from each animal ± sem. (n = 6 
per group). (c) H&E staining on sections from ingSAT of mice at 14 weeks of age. Scale 
bar: 200 µm. (d, e) Relative mRNA expression in ingSAT (d), or pgVAT (e) of mice as 
in (a), or GF mice with respective controls. (n = 6 per group). (f) Immunohistochemistry 
on sections from ingSAT of mice at 14 weeks of age. Bars show mean ± sem from 
automated quantifications of Ucp1-positive cells relative to total cell number. Scale bars: 
200 µm (left) or 100 µm (right). (g) Oxygen consumption rates (OCR) of primary isolated 
ingSAT adipocytes from mice as in (a). Bars represent mean ± sd, calculated using 
averages of two measurements per condition per pooled sample (n) of two mice (n = 4 
samples, 8 mice per group). (h) OGTT of GF mice transplanted with microbiota from 
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control or Abx-treated mice 3.5 weeks after transplantation. Please refer to main text for 
details. (i) ITT of mice as in (h). (j) Relative mRNA expression in ingSAT of mice as in 
(h) 4 weeks after transplantation. All values in (d,e,h-j) show mean ± sd (n = 6 per 
group). Significance was calculated using non-paired two-tailed Students T-test.*: P ≤ 
0.05, **: P ≤ 0.01, ***: P ≤ 0.001. 
 
Figure 3. Microbiota depletion promotes browning in thermoneutral and obese animals 
and improves metabolic disease. (a,d,f) Insulin tolerance tests (ITT) of wild-type mice in 
thermoneutral (30 °C) conditions (a), of ob/ob (d), or HFD (f) 40 days treated Abx, or 
control mice.  (b,e,g) Oral glucose tolerance tests (OGTT) of wild-type mice in 
thermoneutral (30 °C) conditions (b), of ob/ob (e), or HFD (g) 40 days treated Abx, or 
control mice. (c,h,i) Relative mRNA expression in the ingSAT of wild-type mice in 
thermoneutral (30 °C) conditions (c),  ob/ob (h), or HFD (i) 40 days treated Abx, or 
control mice, quantified by real-time PCR and normalized to B2m. All values in (a-i) 
show mean ± sd (n = 6 for each group). (j) Oxygen consumption rates (OCR) of primary 
isolated ingSAT adipocytes from HFD mice as in f), assessed using Clark electrode and 
shown after treatment with the indicated drugs used to dissect the multiple components of 
the cellular respiration, normalized to basal. FCCP: Carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone. Each bar represents mean ± sd, calculated using the 
averages of two measurements per condition per pooled sample (n) of two mice (n = 4 
samples, 8 mice per group). Significance was calculated using non-paired two tailed 
Students T-test. *: P ≤ 0.05, **: P ≤ 0.01, ***: P ≤ 0.001. 
 
Figure 4. Browning of ingSAT after microbiota depletion is mediated by type 2 cytokine 
signaling. (a) Cytokine levels in ingSAT of 12 weeks old Abx, or control mice. (n = 6 per 
group). (b,c) Western blots (b) and quantifications (c) of protein lysates from ingSAT of 
Abx, or control mice after 10, or 60 days antibiotic treatment. (n = 6 per group). γTub: 
γTubulin. (d) Relative Th mRNA expression in ingSAT of mice after 10 and 40 days of 
treatment (n = 6 per group). (e) TH expression in F4/80+ ingSAT SVF of Abx, or control 
mice (n = 8 per group). Y axis shows number of events normalized to the mode. (f,g) 
Frequency of macrophages and eosinophils (f) and Mean Fluorescent Intensity (MFI) of 
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TH or CD301 labeled macrophages (g) in ingSAT SVF of control or Il4ra–/– mice 
following antibiotic treatment (n = 4-6 per group). (h) Eye body temperature of control or 
Il4ra–/– mice, following antibiotic treatment during cold exposure for 12 h. (i) 
Standardized Uptake Values (SUVs) of the radiolabeled tracer [18F]FDG from the 
MicroPET-CT in ingSAT and pgVAT in mice as in (f). (j) MFI of TH, or CD301 labeled 
macrophages in ingSAT tissue of wt mice in thermoneutral (30 °C) conditions treated or 
not with antibiotics for 40 days (n = 6 per group). Values in (a,c,d,f–j) show mean ± sd. 
Significance was calculated using non-paired two tailed Students T-test. *: P ≤ 0.05, **: 
P ≤ 0.01, ***: P ≤ 0.001. 
 
Online Methods 
Animals. All C57Bl/6J (wild-type (wt)), BALB/c and Il4ra–/– mice were purchased from 
Charles River, France; ob/ob mice and respective C57Bl/6J controls were acquired from 
Janvier Labs (France). Mice were kept in a specific pathogen free facility (SPF) in 12 hrs 
day and night cycles and were fed standard chow or high-fat diet (60% Kcal fat, D12492, 
Ssniff, Germany). Germ-free (GF) mice were on C57Bl/6 background from the germ-free 
facility of the University of Bern, and were kept in sterile conditions in 12 hrs day and 
night cycles until sacrifice, unless otherwise stated. Antibiotics were administered in the 
drinking water ad libitum and replaced with freshly-prepared ones every second day, 
similar as described previously21, containing 100µg/ml Neomycin, 50µg/ml 
Streptomycin, 100U/ml Penicillin, 50µg/ml Vancomycine, 100µg/ml Metronidazole, 
1mg/ml Bacitracin, 125µg/ml Ciprofloxacin, 100µg/ml Ceftazidime and 170µg/ml 
Gentamycin (when longer than 40 days treatment) (Sigma, Germany; Alkaloid, 
Macedonia). All antibiotic treatments were started at 8 weeks old animals, and all 
experiments were done in male mice. Cold and thermoneutral exposures were performed 
at 6°C and 30°C respectively, in a light and humidity controlled climatic chamber (TSE, 
Germany) in SPF conditions. Acclimatized animals were allocated to groups based on 
their body weights and blood glucose levels to ensure equal starting points. All mice were 
kept 2 per cage. All animal experiments were approved by the Swiss federal and Geneva 
cantonal authorities for animal experimentation (Office vétérinaire federal and Comission 
cantonale pour les expériences sur les animaux de Genève). 
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Microbiota repopulation. Abx treated mice were repopulated with microbiota from their 
conventional former littermates by cohousing for 7 days immediately after antibiotics 
withdrawal. Mice were analysed at the times indicated in the experiments. For GF 
repopulation, 500 µl of freshly extracted cecal contents from either conventional or Abx 
mice were resuspended in 5 ml of anaerobic PBS and 100 µl of the solution was 
inoculated by oral gavage at days 0 and 2 in each mouse. Animals were kept for 7 days in 
dirty cages from donor group.  Repopulation was confirmed by qPCR. 
 
Hyperinsulinemic euglycemic clamp. Euglycemic hyperinsulinemic clamps were 
performed in conscious unrestrained catheterized mice at the glucose/insulin clamp 
platform, University of Geneva. Seven days prior to the experiment, mice were 
anesthetized using isoflurane and a silastic catheter (0.012 inch inner diameter) was 
surgically implanted in the right jugular vein and exteriorized above the neck using 
vascular access button (Instech Laboratories Inc., Plymouth Meeting, PA). Mice were 
fasted 5 hours before the start of the experiment (t = 0 min). At t = -120 min, an infusion 
of [1-3H] glucose (0.05 µCi/min) (Perkin Elmer, Walthman, MA, USA) was initiated. 
After 120 min, blood samples were collected from the tail vein to measure basal blood 
glucose and plasma insulin as well as to calculate the rate of endogenous glucose 
appearance (EndoRa) and glucose disposal (Rd) at basal state. At t = 0 min, a continuous 
insulin infusion (4 mIU/kg body weight/min.) (NovoRapid, Novo Nordisk Pharma, 
Zurich, Switzerland) was used to induce hyperinsulinemia. The infusion of [3-3H] 
glucose was increased to 0.1 µCi/min and 50% glucose was infused to maintain target 
euglycemia (120 mg/dL) (glucose infusion rate, GIR). At steady state, in vivo insulin-
stimulated glucose uptake in tissues was determined by a 10 µCi bolus injection of 2-
[14C] deoxyglucose (2[14C]DG) (Perkin Elmer). After 30 min, mice were killed by 
cervical dislocation and tissues removed and stored at -80°C until use.  [3-3H] glucose 
and 2[14C]DG specific activities were determined in deproteinized blood samples. Plasma 
insulin was measured by ELISA (Mercodia, Uppsala, Sweden). EndoRa under insulin 
stimulated state was determined by subtracting steady state GIR from Rd. Measurements 
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of 2-[14C] deoxyglucose-6-phosphate concentration allowed calculation of the glucose 
utilization index of individual tissues. 
 
Positron emission tomography - computed tomography (MicroPET-CT). Mice were 
anesthetized with 2% isoflurane and were injected in the venous sinus with 5-6 MBq of 
2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG). Mice were then left awake at room 
temperature or at 4°C during the uptake time of 60 min. 10 min prior to positron emission 
tomography (PET) scan, mice were injected intraperitoneally with 700 µL of 132 mg/mL 
meglumine ioxitalamate (Telebrix, 6 % m/v iodide, Guerbet AG, Zürich, Switzerland) to 
delineate the abdominal region and subjected to computed tomography (CT) scans in a 
Triumph microPET/SPECT/CT system (Trifoil, Chatsworth, CA, USA). Images were 
obtained at 80 kVp, 160 µA, and 1024 projections were acquired during the 360° rotation 
with a field of view of 71.3 mm (1.7 × magnification). After 60 min of [18F]FDG uptake, 
PET scans were started for a total duration of 20 min. PET scans were reconstructed with 
the built-in LabPET software using an OSEM3D (20 iterations) algorithm and images 
were calibrated in Bq / mL by scanning a phantom cylinder. The Triumph XO software, 
which uses a back-projection engine, was used to reconstruct the CT scans with a matrix 
of 512 and a voxel size of 0.135 mm. CT scans were co-registered with the PET scans 
using the plugin Vivid (Trifoil) for Amira (FEI, Hillsboro, OR, USA) and exported as 
dicom files. The software Osirix (Pixmeo, Bernex, Switzerland) was used to 
quantitatively analyse the datasets and generate pictures. Regions of interest (ROI) were 
drawn on contiguous slices on CT scans and computed as 3D volumes for the 
measurements of volumes and densities of indicated adipose tissues. Then, PET series 
were converted to display Standardised Uptake Values (SUV) adjusted to the body 
weight of the animals and merged with CT sets. 3D ROIs derived from CT scans were 
used to quantify the uptake of [18F]FDG in the indicated adipose tissues. In order to 
measure the volume of activated interscapular BAT, a 3D ROI was first delineated 
visually by contouring the [18F]FDG activity. A new ROI was then derived based on a 
threshold equal to the mean [18F]FDG minus one standard deviation of all voxels within 
the primary defined ROI. This final volume was used to report the activated BAT. 
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2-[1-3H]deoxyglucose (2DG) uptake. In vivo insulin-stimulated glucose uptake in 
tissues during the IPGTT was determined by the concomitant injection of 40 µCi of 2DG 
(Perkin Elmer) with the glucose load (i.p., 2g/kg BW). 2DG specific activity was 
determined in deproteinized blood samples collected from the tail vein 5, 15, 30 and 45 
min after injection. At 45 min, mice were rapidly killed and tissues removed and stored at 
-80°C until use. Measurements of 2-[1-3H]deoxyglucose-6-phosphate concentration 
allowed calculation of the glucose utilization index by individual tissues. 
 
Flow cytometry and characterization of hematopoietic cell populations. Primary 
stromal vascular fractions (SVF) from ingSAT, pgVAT and iBAT were prepared as 
described22,23. Cells were washed in phosphate-buffered saline (PBS) supplemented with 
0.1% BSA and 0.5 mM EDTA, pH 8.0, and stained when appropriate with rat 
monoclonal anti-F4/80 (Clone A3-1, cat # ab105155, 1:200, Abcam), rat monoclonal 
anti-CD11b (Clone M1/70, cat # 561114, 1:200, BD Biosciences) and rat monoclonal 
anti-CD301 (Clone LOM-14, cat # 145705, 1:400, BioLegend) for macrophage staining, 
or rat monoclonal anti-CD45 (Clone 104, cat #558702, 1:200, BD Biosciences) and rat 
monoclonal anti-Siglec F (Clone E50-2440, cat # 562068, 1:200, BD Biosciences) for 
eosinophil staining. For intracellular markers, cells were subsequently washed again, 
fixed in 2% paraformaldehyde, then labeled with rat monoclonal anti-NOS2 (Clone 
CXNFT, cat # 61-5920, eBioscience) and rabbit monoclonal anti-TH (Clone EP1533Y, 
cat # TA303716, 1:50, Origene) and polyclonal goat anti-rabbit secondary antibody (cat # 
A-10931, 1:400, Thermo Fisher Scientific) in permeabilization buffer (PBS with 0.5% 
Tween 20). Data were acquired using a Gallios Flow Cytometer (Beckman Coulter) and 
analyzed with FlowJo v10 software. After gating out dead cells and doublets, 
macrophages were identified as CD11b+F4/80+ and eosinophils were detected as 
CD45+Siglec-F+ cells. 
 
Calorie uptake. Mice were housed 2 per cage, and food intake and feces production 
were measured and collected per 24 h. The feces were dried and ground to a fine powder 
before subjecting them to an oxygen bomb calorimeter (Parr, 6100, USA) according to 
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the manufacturers instructions. Calorie excretion was calculated by multiplying the 
produced feces with the calories content per gram feces.  
 
Histology, Immunofluorescence and western blotting (WB). Tissues were extracted, 
fixed in 4% paraformaldehyde (Sigma), paraffin embedded, cut in 5 µm thick sections 
and stained with hematoxylin-eosin (H&E) using standard techniques. 
Immunohistochemistry was done using rabbit anti-UCP1 (Pierce PA1-24894, 1:100) and 
anti-rabbit Cy3 (Jackson 711165152, 1:250) secondary antibody. Images were acquired 
using Mirax (Zeiss) and the cell/lipid droplet size quantification was performed using 
MetaMorph software (V7.7.6.0, Molecular Devices). WB was done on 10-20µg total 
lysates using rabbit anti-TH (OriGene TA303716, 1:1000), and mouse anti-γ-tubulin 
(Sigma T6557, 1:5000).  
 
Metabolic experiments. Body temperature was read with infrared camera FLIR E60 
(FLIR, UK) from 40cm distance and the data was analyzed by FLIR Tools+ software. We 
confirmed the consistency with the results by rectal body temperature measurements.  
Glucose tolerance tests were performed after 6 h fasting by intraperitoneal injection or 
oral gavage of glucose bolus (2g/kg BW). Insulin tolerance test was performed after a 5 h 
daytime fast, 0.5U/kg except for HFD-fed mice (0.75U/kg) and ob/ob mice (2U/kg) 
(Sigma Aldrich I9278). All mice were sacrificed after 5h fasting. 500µl of blood was 
taken from terminally anesthetized mice in tubes with 15µl of 0.5 mM EDTA, 4 µl of 
aprotinin and 4 µl of DPPIV and plasma stored at -80 °C.  
 
Serum T3. Serum concentration of T3 (MyBioSource) was detected following 
manufacturers instruction. 
 
Oxygen consumption rates (OCR). Oxygen consumption of isolated mature adipocytes 
from ingSAT was measured in Clark-type electrode (Rank Brothers Ltd., Cambridge, 
UK). Mature adipocytes were separated from stromal vascular fraction as previously 
described21,22,25 and resuspended in respiration buffer (250 mM sucrose, 50 mM KCl, 20 
mM Tris/HCl, 1 mM MgCl2, 5 mM KH2PO4 and 20µM EGTA at pH 7.0). Respiration 
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was assessed at basal state, and under β–adrenergic stimulation (10 µΜ isoproterenol). 20 
mM oligomycin, 100 nM carbonyl cyanide-4-phenylhydrazone (FCCP) and 20 µM 
rotenone were added in 5-15 minutes intervals. Consumption values were normalized to 
extracted DNA from final mixture. Oxygen consumption was repeated two times for each 
replicate. 
 
Real Time PCR. One µg of total RNA was used for cDNA preparation with random 
hexamer primers using High Capacity cDNA Reverse Transcription kit (Applied 
Biosystems). Steady-state mRNA expression was measured by quantitative real-time 
PCR using the LightCycler 480 SYBR Green Master I Mix (Roche) with a Mx3005P 
Real Time PCR System (Stratagene), or 386 well LightCycler 480 II (Roche). Transcript 
levels were normalized to house keeping beta-2-microglobulin (B2m). Primer sequences 
for real-time PCRs are as previously used22,23, together with the following for Th: 5’-
GGTATACGCCACGCTGAAGG-3’ (F) and 5’-TAGCCACAGTACCGTTCCAGA-3’ 
(R). 
 
Statistics. Unless otherwise specified in the figure legends, significance was calculated 
using non-paired two tailed Students t test.*P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, and 
values show mean ± sd. Sample sizes and animal numbers were chosen based on power 
calculations of 0.8. All experiments were independently performed at least three times 
without blinding, and representative values from one experiment are shown. No animals 
or values were excluded from the analysis.  
 
Methods-only references  
21 Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products 
drive IL-23/IL-17-mediated tumour growth. Nature 491, 254-258, 
doi:10.1038/nature11465 (2012). 
22 Sun, L. & Trajkovski, M. MiR-27 orchestrates the transcriptional regulation of 
brown adipogenesis. Metabolism 63, 272-282, doi:10.1016/j.metabol.2013.10.004 
(2014). 
23 Trajkovski, M., Ahmed, K., Esau, C. C. & Stoffel, M. MyomiR-133 regulates 
brown fat differentiation through Prdm16. Nat Cell Biol 14, 1330-1335, 
doi:ncb2612 [pii]10.1038/ncb2612 (2012). 
 17 
24 Frezza, C., Cipolat, S. & Scorrano, L. Organelle isolation: functional 
mitochondria from mouse liver, muscle and cultured fibroblasts. Nature protocols 
2, 287-295, doi:10.1038/nprot.2006.478 (2007). 
25 Trajkovski, M. et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 
474, 649-653, doi:nature10112 [pii] 10.1038/nature10112 (2011). 
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Supplementary Figure 1. Microbiota depletion improves glucose homeostasis. (a,b) 
Intraperitoneal glucose tolerance tests (IPGTT) on Abx (a), or GF mice (b) compared 
to the respective controls. (c) Random blood glucose levels during the antibiotic treat-
ment as in (a). (d) Fecal content cultured on 5% sheep blood agar plates from mice 
as in (a) in anaerobic and aerobic conditions. All values show mean ± sd (n = 8 per 
group). Significance was calculated using non-paired two tailed Students t-test.*: P ≤ 
0.05, **: P ≤ 0.01, ***: P ≤ 0.001.
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Supplementary Figure 2. Microbiota depletion promotes glucose uptake preferentially in white 
fat under hyperinsulinemic conditions.  (a,b) Basal and final insulin levels (a) and glucose 
infusion rates (GIR, b) during hyperinsulinemic-euglycemic clamp in awake and unrestrained 
C57Bl6/J mice as in Fig. 1e. (c–h) Assessment of the tissue-specific glucose uptake 2[14C]de-
oxyglucose (2[14C]DG) in iBAT (c), ingSAT (2nd depot) (d), quadriceps (e), brain (f), and soleus 
(h); or hepatic glucose production (HGP) (g) during hyperinsulinemic-euglycemic clamp in 
awake C57Bl6/J mice as in Fig. 1e. All bars show mean ± sd (n = 6 per group). Significance was 
calculated using non-paired two tailed Students t-test.*: P ≤ 0.05, **: P ≤ 0.01, ***: P ≤ 0.001.
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Supplementary Figure 3. Increased white fat glucose uptake after microbiota depletion at basal 
conditions. (a,b) Standardized Uptake Values (SUVs) of the radiolabeled tracer 2-deoxy-2-[18F]-
fluoro-D-glucose ([18F]FDG) from the MicroPET-CT in iBAT (a) and pgVAT (b), in mice kept at room 
temperature, or exposed to 6 °C for 12 h as in Fig. 1h. (c) Coronal view of the CT in Control and Abx 
mice. (d) Transversal [18F]FDG PET-CT images of ingSAT in Control and Abx mice at RT and after 12 
h exposure to 6 °C. (e–h) 2-[1-3H]deoxyglucose (2-[3H]DG) uptake during IPGTT in ingSAT (e), pgVAT 
(f), iBAT (g), and quadriceps (h) in 11 weeks old Abx and Control C57Bl6/J. (i) PET-CT measurement 
of activated iBAT volume in 12 weeks old Abx and Control C57Bl6/J mice exposed to cold for 12 h as 
in Fig. 1h. (j) Density of the pgVAT represented in Hounsfield units. All bars show mean ± sd (n = 6 
per group). Significance was calculated using non-paired two tailed Students t-test.*: P ≤ 0.05, **: P 
≤ 0.01, ***: P ≤ 0.001.
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sample. (e) Body weight in the course of the antibiotic treatment experiment of mice as in (a). (f) Excised 
adipose tissue weights after sacrifice of GF or control mice (n = 6 per group). (g) Multidetector computed 
tomography (CT) measurements of different fat depots. (h) Representative ingSAT, pgVAT, perirenalWAT, 
iBAT, and interscapular SAT (iSAT) images from mice as in (a). All bars show mean ± sd. Significance was 
calculated using non-paired two tailed Students t-test.*: P ≤ 0.05, **: P ≤ 0.01, ***: P ≤ 0.001.
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Supplementary Figure 5. Microbiota depletion promotes browning. (a) Hematoxylin and eosin (H&E) staining on paraffin 
sections from pgVAT of mice at 14 weeks of age. (b) Immunohistochemistry of paraffin sections from pgVAT of  mice at 14 
weeks of age. (c) Serum 3,5,3'-Triiodothyronine (T3) levels in Control, Abx, or GF mice at 14 weeks of age. (d–g) Relative 
mRNA expression in ingSAT (d,e), or pgVAT (f,g) of Abx mice and respective controls after 10 days (d,f), and 60 days (e, 
g) of antibiotic treatment, quantified by real-time PCR and normalized to the house keeping beta-2-microglobulin (B2m). (n 
= 6 per group). (h) Bomb calorimetric measurements of 24 h fecal calories content of 12 weeks old Control, or Abx mice. 
Mice (n = 8 per group) were kept 2 mice per cage. Each cage was considered as one pooled sample. (i,j) Rectal tempera-
ture (i) and blood glucose levels (j)  following cold exposure for 12 h (n = 8 per group). Lines show mean. (k,m,n)  Relative 
mRNA expression in ingSAT of Control wt, or Abx mice 10 days after repopulation (Abx repopulated) (k); or of GF mice 
without, or 5 and 7 weeks after transplantation (GF conventionalized) (m,n), quantified by real-time PCR and normalized 
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wt (GF conventionalized), or Abx mice. The antibiotic treatment of the recipient GF mice getting the Abx microbiota was 
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Supplementary Figure 6. Loss of browning in conven-
tionalized GF and Abx mice. (a) Excised organ weights 
after sacrifice of GF mice transplanted with microbiota 
from control wt (GF conventionalized), or Abx mice. 
The antibiotic treatment of the recipient GF mice trans-
planted with the residual Abx microbiota was continued 
or not (GFAbxT, or GFAbxTstop, respectively). All 
values show mean ± sd (n = 6 per group).  (b) Relative 
mRNA expression in ingSAT of GF mice as in (a), 
quantified by real-time PCR and normalized to B2m. All 
values show mean ± sd (n = 6 per group). (c,d) Cell 
size profiling of adipocytes in ingSAT (c), or pgVAT (d) 
of mice as in (a). The values show % from the total 
number of analyzed cells. Bars show mean of 
the pooled corresponding fractions from each animal ± sd (n = 6 per group). (e) Oral glucose tolerance tests (OGTT) 
of Control and 12 weeks antibiotic treated mice conventionalized or not with microbiota from control wt after 8 weeks 
of treatment (Abx conventionalized); or in which the antibiotic treatment was stopped at the 8th week and allowed 
repopulation to occur from the residual microbiota (Abx stop) (n = 6 per group). (f) Insulin tolerance tests (ITT) of mice 
as in (e). (g,h) Relative mRNA expression in ingSAT (g), or pgVAT (h) of mice as in (e) 12 weeks after antibiotics initia-
tion. Repopulation was done for four weeks. (n = 4 per group). Values show mean ± sd. Significance was calculated 
using two way Anova. *: P ≤ 0.05, **: P ≤ 0.01, ***: P ≤ 0.001.
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Supplementary Figure 7. The metabolic improvements are maintained at thermoneutrality and in obese mice. 
(a) Insulin tolerance tests (ITT) of Abx, or control mice kept at thermoneutrality after 40 days of treatment. Starting 
values are normalized to 1. (b) Relative mRNA expression in pgVAT of mice as in a), quantified by real-time PCR 
and normalized to B2m. (c) Weight of fat tissues of mice as in (a). All values in (a-c) show mean ± sd (n = 6 per 
group). (d,e) Cell size profiling of adipocytes in ingSAT (d) and pgVAT (e) of mice as in (a). The values show % 
from the total number of analyzed cells. Bars show mean of the pooled corresponding fractions from each animal 
± sd (n = 6 for each panel). (f,g) Relative mRNA expression in pgVAT of ob/ob (f), or HFD fed (g) Control or Abx 
mice quantified by real-time PCR and normalized to B2m. (h) Organ weights of chow fed, or HFD mice treated or 
not with antibiotics for 40 days. (n = 6 per group). Significance was calculated using non-paired two tailed 
Students t-test. *: P ≤ 0.05, **: P ≤ 0.01, ***: P ≤ 0.001.
IngSAT cytokines (pg/ml) 
Supplementary Figure 8
b
Control (pg/ml) Abx (pg/ml) Control sd Abx sd p-value
IL-1a 26.33 36.58 22.166 11.199 0.3830
IL-1b 269.321667 376.65 41.601 21.923 0.0006
IL-2 87.78 126.022 52.038 21.648 0.1677
IL-3 7.37 10.344 2.120 2.145 0.0466
IL-4 4.522 7.286 0.852 0.661 0.0004
IL-5 7.06166667 9.956 1.742 2.035 0.0314
IL-6 16.63 28.032 5.290 15.233 0.1525
IL-9 318.705 511.086 71.513 56.320 0.0009
IL-10 36.8016667 60.056 7.438 9.362 0.0013
IL-12(p40) 20.346 38.246 17.274 12.443 0.0969
IL-12(p70) 131.775 208.644 46.827 54.684 0.0330
IL-13 211.266 362.168 54.742 26.318 0.0005
IL-17 19.0883333 37.6 6.212 21.687 0.0749
Eotaxin 706.023333 823.68 122.339 69.640 0.0900
G-CSF 6.185 7.742 2.021 0.951 0.1501
GM-CSF 74.2483333 90.73 17.522 14.299 0.1266
IFN-g 19.0616667 27.012 2.932 5.308 0.0116
KC 9.22 16.64 2.870 3.823 0.0051
MCP-1 129.288333 176.99 12.244 19.225 0.0007
MIP-1a 7.50833333 12.94 3.327 2.244 0.0128
MIP-1b 79.6366667 96.454 18.651 20.266 0.1858
RANTES 15.3666667 22.624 9.226 1.089 0.1171
TNF-a 588.811667 788.51 200.519 54.785 0.0607
Jejunum cytokines (pg/ml) 
Control (pg/ml) Abx (pg/ml) Control sd Abx sd p-value
IL-1a 93.78 57.49 3.656 25.995 0.1593
IL-1b 298.33 281.67 10.373 12.080 0.2119
IL-2 60.72 100.66 0.750 31.561 0.1881
IL-3 16.20 16.76 3.642 1.615 0.8181
IL-4 4.79 4.66 0.601 0.199 0.7508
IL-5 6.94 11.32 0.000 4.686 0.2984
IL-6 36.69 38.48 1.188 1.923 0.3354
IL-9 254.77 396.50 26.311 99.210 0.1561
IL-10 29.91 30.61 3.797 0.665 0.7560
IL-12(p40) 33.74 32.75 6.286 3.601 0.8327
IL-12(p70) 812.65 812.62 7.997 82.848 0.9997
IL-13 252.02 253.18 5.190 14.823 0.9250
IL-17 17.11 18.54 3.889 0.699 0.5465
Eotaxin 539.55 550.62 13.336 16.603 0.4935
G-CSF 11.19 11.45 4.306 0.800 0.9162
GM-CSF 84.36 80.20 1.011 6.817 0.4756
IFN-g 32.08 40.34 1.082 7.879 0.2556
KC 6.20 7.27 0.594 1.266 0.3606
MCP-1 113.16 129.34 5.134 9.156 0.1147
MIP-1a 13.25 13.08 0.290 1.549 0.8942
MIP-1b 98.72 100.32 15.889 9.841 0.8945
RANTES 26.28 29.46 1.280 4.153 0.3888
TNF-a 1033.01 1082.85 156.348 70.317 0.6450
a
Supplementary Figure 8. Increased cytokine levels in white 
adipose tissue of Abx mice. (a,b) Tables representing ingSAT (a), 
or jejunal (b) cytokine levels measured in 12 weeks old Abx, or 
control mice (n = 8 per group). Significance was calculated using 
non-paired two tailed Students t-test. 
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Supplementary Figure 9. Microbiota depletion increases type 2 cytokine signaling in white fat. (a,b) 
Cytokine levels measured in pgVAT (a), or iBAT (b) of 12 weeks old Abx, or control mice. Bars show mean ± 
sd (n = 8 per group). (c–e) Frequency of TH+ macrophages (c) and CD11b+ F4/80+ cells (d–e) in ingSAT SVF 
of Abx, or control mice. (f, g) F4/80+ cells abundance in iBAT of Abx, or control mice. FSC: forward-scattered 
light. (h) Eosinophils abundance in iBAT of mice as in (f). (i–k) Mean Fluorescent intensity (MFI) of NOS2 
(M1), or CD301 (M2) labeled macrophages shown as arbitrary units (a.u.) in ingSAT SVF of 40 days treated 
Abx and control mice. Bars show mean of two pooled groups with four mice each (g)  or eight mice analyzed 
separately (c,e,h,k) ± sd. Y axis in (i,j) shows number of events normalized to the mode. *: P ≤ 0.05, **: P ≤ 
0.01, ***: P ≤ 0.001.
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Supplementary Figure 10. Loss of type 2 signaling 
impairs browning of Abx mice. (a,b) Eye body temper-
ature of control Il4ra+/+ (n = 6 per group) (a) or Il4ra-/- 
(n = 4 per group) (b) mice, following antibiotic treat-
ment during cold exposure of 12 h. (c) Temperature 
change of Abx vs. control mice in Il4ra+/+ and Il4ra-/- 
during cold exposure of 12 hrs. (d,e) Oral glucose 
tolerance tests (OGTT) of control Il4ra+/+ (d) or Il4ra-/- 
(e) mice as in (a, b), following antibiotic treatment 
compared to the respective controls. (f) Insulin toler-
ance tests (ITT) of mice as in (e). (g) Macrophage and 
eosinophil abundance in pgVAT of Control Il4ra+/+ or 
Il4ra-/- mice Abx or control mice after 40 days of treat-
ment. (h) Mean Fluorescent intensity (MFI) of TH, or 
CD301 labeled macrophages shown as arbitrary units 
(a.u.) in pgVAT tissue of control Il4ra+/+ or Il4ra-/- mice 
following 40 days antibiotic treatment compared to 
respective controls. (i) Relative mRNA expression in 
ingSAT and pgVAT of Il4ra-/- mice with or without 40 
days antibiotic treatment quantified by real-time PCR 
and normalized to B2m (n = 4 per group). (j,k) Mac-
rophage and eosinophil abundance in ingSAT (j), and 
pgVAT (k) SVF of control or Abx mice kept at thermo-
neutrality. (l) Mean Fluorescent intensity (MFI) of TH, 
or CD301 labeled cells shown as arbitrary units (a.u.) 
in pgVAT tissue of mice as in (k).  All values show 
mean ± sd. (n = 4-6 per group). Significance was 
calculated using non-paired two tailed Students t-test. 
*: P ≤ 0.05, **: P ≤ 0.01, ***: P ≤ 0.001.
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